A NOVEL OSTEOGENIC ACTIVITY ASSOCIATED WITH SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) IS SYNERGIZED WITH BMP-2

被引：0
|
作者：
Lee, Z. H. [1 ]
机构：
[1] Seoul Natl Univ, Sch Dent, Cell & Dev Biol, Seoul, South Korea
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.1481
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0032
引用
收藏
页码：660 / 660
页数：1
相关论文
共 50 条
  • [1] The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA)
    Marks, PA
    [J]. CELL CYCLE, 2004, 3 (05) : 534 - 535
  • [2] Synergistic Preclinical Activity of Bortezomib with Suberoylanilide Hydroxamic Acid (SAHA) in Primary Effusion Lymphoma (PEL)
    Bhatt, Shruti
    Ashlock, Brittany
    Toomey, Ngoc
    Mesri, Enrique
    Ramos, Juan Carlos
    Lossos, Izidore S.
    [J]. BLOOD, 2011, 118 (21) : 717 - 718
  • [3] The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma
    Ghayad, Sandra E.
    Rammal, Ghina
    Sarkis, Omar
    Basma, Hussein
    Ghamloush, Farah
    Fahs, Assil
    Karam, Mia
    Harajli, Mohamad
    Rabeh, Wissam
    Mouawad, Joe E.
    Zalzali, Hassan
    Saab, Raya
    [J]. CANCER BIOLOGY & THERAPY, 2019, 20 (03) : 272 - 283
  • [4] Anticancer effects of suberoylanilide hydroxamic Acid (SAHA) in esophageal squamous cell carcinoma
    Tzao, Ching
    Chen, Ban-Hen
    Hsu, Ting-Yun
    Sun, Guang-Huan
    Chiou, Shi-Hwa
    Lee, Shih-Chun
    [J]. CANCER RESEARCH, 2009, 69
  • [5] Suberoylanilide Hydroxamic Acid (SAHA) Is a Driver Molecule of Neuroplasticity: Implication for Neurological Diseases
    Verrillo, Lucia
    Di Palma, Rosita
    de Bellis, Alberto
    Drongitis, Denise
    Miano, Maria Giuseppina
    [J]. BIOMOLECULES, 2023, 13 (09)
  • [6] Histone deacetylase inhibitors: Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers
    Richon, VM
    Zhou, XB
    Rifkind, RA
    Marks, PA
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2001, 27 (01) : 260 - 264
  • [7] The hybrid polar cytodifferentiation agent suberoylanilide hydroxamic acid (SAHA) is a potent inhibitor of histone deacetylase activity.
    Richon, VM
    Breslow, R
    Rifkind, RA
    Marks, PA
    [J]. BLOOD, 1998, 92 (10) : 598A - 598A
  • [8] Suberoylanilide hydroxamic acid (SAHA) induces apoptosis or autophagy-associated cell death in chondrosarcoma cell lines
    Yamamoto, Shunsaku
    Tanaka, Kazuhiro
    Sakimura, Riku
    Okada, Takamitsu
    Nakamura, Tomoyuki
    Li, Yan
    Takasaki, Minoru
    Nakabeppu, Yusaku
    Iwamoto, Yukihide
    [J]. ANTICANCER RESEARCH, 2008, 28 (3A) : 1585 - 1591
  • [9] The osteogenic activity of β-catenin requires interaction with BMP-2 effectors
    Mbalaviele, G
    Sheikh, S
    Cheng, S
    Stains, J
    Civitelli, R
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S14 - S14
  • [10] A novel field of action for suberoylanilide hydroxamic acid (SAHA) in leukemic cells: regulation of cellular adhesivity to extracellular matrix
    Kuzelova, K.
    Pluskalova, M.
    Grebenova, D.
    Hrkal, Z.
    [J]. FEBS JOURNAL, 2009, 276 : 322 - 322
12345